Advanced Search

 

Study ID Status Title Patient Level Data
S3A30067 Completed Ondansetron plus Placebo versus Ondansetron plus Dexamethasone under consideration of a risk score for the prophylaxis of post operative nausea and vomiting (PONV)
S3A-351 Completed A Single-Blind Evaluation of Intravenous GR-C507/75 Compared to Intravenous Metoclopramide in the Prevention of Nausea and Vomiting Associated With High-Dose Cisplatin
S3A-352 Completed A Randomized Double-Blind Comparison of Three Dose Levels of Intravenous GR-C507/75 (GR 38032F) in the Prevention of Nausea and Vomiting Associated with Cisplatin
S3A-354 Completed A Double-Blind Comparison of Intravenous GR-C507/75 (GR38032F) and Placebo in the Prevention of Nausea and Vomiting Associated With Cisplatin or Cyclophosphamide Chemotherapy
S3A356 Completed A Double-Blind Evaluation of Three Different Doses of Intravenous GR-C507/75 (Ondansetron) in the Prevention of Nausea and Vomiting Associated With a Multiple Day Regimen of Cisplatin
S3A-359 Completed A Randomized Double-Blind Comparison of Three Dose Levels of Intravenous GR-C507/75 in the Prevention of Nausea and Vomiting Associated With Cisplatin
S3A362 Completed A Randomized, Double-Blind, Placebo-Controlled Dose Range Evaluation of Oral GR 38032F in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy
S3A372 Completed A Double-Blind, Placebo-Controlled Study of Oral Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Female Patients
S3A-375 Completed A Randomized, Double-Blind, Placebo-Controlled Evaluation of Oral Ondansetron Administered Twice Daily in the Prevention of Nausea and Vomiting Associated with Non-Cisplatin Chemotherapy
S3A-376 Completed A Stratified, Randomized, Double-Blind, Comparison of Oral Ondansetron Administered Twice Daily Versus Three Times Daily in the Prevention of Nausea and Vomiting Associated with Non-Cisplatin Chemotherapy
S3A40022 Completed Open-label multicentre-study to evaluate efficacy and tolerability of a novel fast-dissolving formulation of ondansetron to prevent nausea and vomiting after therapy with non-platinum-containing chemotherapy in paediatric patients.
S3A40065 Completed A Randomized, Double-Blind, Placebo-Controlled Dose Range Evaluation of Oral GR 38032F in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy
S3A40068 Completed Randomised, double-blind, placebo-controlled, multicentre, parallel group study to evaluate the efficacy and safety of a Zofran iv in the prevention of PONV in major gynaecological surgery.
S3A40069 Completed Randomised single centre double-blind study to compare the efficacy and safety of a single iv dose of Zofran administered either prior to induction or prior to cessation of anaesthesia in the prevention of PONV in patients having general anaesthesia and undergoing major surgery.
S3A40092 Completed A randomized, double blind, parallel group study to compare the efficacy and tolerability of ondansetron vs metoclopramide in the prevention of post-operative nausea and vomiting in patients undergoing ophthalmic surgery
S3A40095 Completed An assessment of the effect of schedule and maintenance on the antiemetic efficacy and safety of ondansetron combined with dexamethasone as acute and maintenance therapy in patients receiving moderately emetogenic chemotherapy.
S3A40121 Completed A Multicentre Double-Blind Crossover Study to Compare the Efficacy and Safety of GR38032F with Metoclopramide in the Prophylaxis of Acute Nausea and Vomiting Induced by Cisplatin-Containing Cancer Chemotherapy Regimens
S3A40125 Completed A randomised double-blind multicentre study to compare the clinical efficacy and safety of ondansetron (GR38032) and prochlorperazine in the prophylaxis of nausea and vomiting caused by fractionated radiotherapy
S3A40128 Completed A Randomised, Double-blind Study to Compare the Efficacy and Safety of Ondansetron (GR38032) Administered as Either a Single IV Dose or a Continuous Infusion Over 24 hours In Acute Cisplatin-induced Emesis
S3A40131 Completed An open non-comparative single centre study to assess the efficacy and safety of ondansetron in the prophylaxis of cancer chemotherapy-induced nausea and vomiting in children.
S3A40168 Completed A Randomized, Double-Blind, Placebo-Controlled Evaluation of Efficacy and Pharmacokinetic Parameters of Oral Ondansetron in the Prevention of Nausea and Vomiting Associated With Fractionated Total Body Irradiation
S3A40169 Completed An Open-Label Evaluation of Ondansetron Versus Ondansetron Plus Dexamethasone and Chlorpromazine in the Prevention of Nausea and Vomiting Associated with Multiple-Day Cisplatin Chemotherapy
S3A40175 Completed A single blind, placebo-controlled, multicentre study of intravenous ondansetron in the prevention of post-operative emesis (retching and vomiting) in paediatric patients undergoing strabismus surgery.
S3A40181 Completed A Randomized, Double-Blind Comparison of Oral Ondansetron and Compazine® Spansules® in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy
S3A40182 Completed A Stratified, Randomized, Double-Blind Comparison of Intravenous Ondansetron Administered as a Multiple Dose Regimen Versus Two Single Dose Regimens in the Prevention of Cisplatin-Induced Nausea and Vomiting

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.